| Literature DB >> 18329760 |
Jennifer A McWilliams1, Richard T Sullivan1, Kimberly R Jordan1, Rachel H McMahan1, Charles B Kemmler1, Marcia McDuffie2, Jill E Slansky1.
Abstract
Immunologic tolerance to endogenous antigens reduces antitumor responses. Gp70 is an endogenous tumor-associated antigen (TAA) of the BALB/c-derived colon carcinoma CT26. We found that expression of gp70 mRNA is detectable in tissues of mice 8 months of age and older. We showed that expression of gp70 establishes immunologic tolerance and affects antitumor immunity in a similarly age-dependent manner using gp70-deficient mice. We found that tumors grew in all gp70-sufficient mice, while approximately half of gp70-deficient mice controlled tumor growth with endogenous T-cell responses. Protection in gp70-deficient mice correlated with more robust gp70-specific CTL responses, and increased numbers and avidity of responding antigen-specific T cells after vaccination. We conclude that immunosurveillance may decline with age due to increased or de novo peripheral expression of endogenous TAAs.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18329760 PMCID: PMC2295286 DOI: 10.1016/j.vaccine.2008.01.052
Source DB: PubMed Journal: Vaccine ISSN: 0264-410X Impact factor: 3.641